Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 256 | $189,929,373 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
14 Feb 2023 17:08 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 13 Feb 2023 | Sale | 113 | 300.39 | 33,944 | D |
14 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 13 Feb 2023 | Sale | 835 | 300.13 | 250,609 | D |
14 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 13 Feb 2023 | Sale | 1,779 | 299.26 | 532,384 | D |
14 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 13 Feb 2023 | Sale | 2,028 | 298.42 | 605,196 | D |
14 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 13 Feb 2023 | Sale | 245 | 296.44 | 72,628 | D |
14 Feb 2023 16:49 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 13 Feb 2023 | Sale | 500 | 300.23 | 150,115 | D |
14 Feb 2023 16:49 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 13 Feb 2023 | Sale | 1,893 | 299.36 | 566,688 | D |
14 Feb 2023 16:49 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 13 Feb 2023 | Sale | 2,160 | 298.47 | 644,695 | D |
14 Feb 2023 16:49 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 13 Feb 2023 | Sale | 245 | 296.44 | 72,628 | D |
08 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 06 Feb 2023 | Sale | 153 | 309.06 | 47,286 | D |
08 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 06 Feb 2023 | Sale | 620 | 306.7 | 190,154 | D |
08 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 06 Feb 2023 | Sale | 349 | 305.08 | 106,473 | D |
08 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 06 Feb 2023 | Sale | 100 | 303.64 | 30,364 | D |
08 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 06 Feb 2023 | Sale | 70 | 302 | 21,140 | D |
08 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 06 Feb 2023 | Sale | 12 | 300.39 | 3,605 | D |
02 Feb 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 31 Jan 2023 | Sale | 106 | 325 | 34,450 | D |
02 Feb 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | SACHS BRUCE I | Director | 31 Jan 2023 | Sale | 1,200 | 325.01 | 390,012 | D |
31 Jan 2023 16:45 | VRTX | VERTEX PHARMACEUTICALS INC | CARNEY LLOYD | Director | 30 Jan 2023 | Sale | 324 | 321.84 | 104,276 | D |
31 Jan 2023 16:45 | VRTX | VERTEX PHARMACEUTICALS INC | CARNEY LLOYD | Director | 30 Jan 2023 | Sale | 1,000 | 320.7 | 320,700 | D |
31 Jan 2023 16:45 | VRTX | VERTEX PHARMACEUTICALS INC | CARNEY LLOYD | Director | 30 Jan 2023 | Sale | 1,376 | 320.08 | 440,430 | D |
31 Jan 2023 16:42 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 27 Jan 2023 | Sale | 80 | 323.33 | 25,866 | D |
31 Jan 2023 16:42 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 27 Jan 2023 | Sale | 970 | 322.2 | 312,534 | D |
31 Jan 2023 16:42 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 27 Jan 2023 | Sale | 379 | 321.31 | 121,776 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 26 Jan 2023 | Sale | 680 | 320.94 | 218,239 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 26 Jan 2023 | Sale | 400 | 320.25 | 128,100 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 26 Jan 2023 | Sale | 478 | 319.25 | 152,602 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 26 Jan 2023 | Sale | 1,000 | 317.95 | 317,950 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 26 Jan 2023 | Sale | 1,140 | 316.82 | 361,175 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 26 Jan 2023 | Sale | 302 | 315.42 | 95,257 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 25 Jan 2023 | Sale | 579 | 314.95 | 182,356 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 25 Jan 2023 | Sale | 2,621 | 314.1 | 823,256 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 25 Jan 2023 | Sale | 800 | 312.8 | 250,240 | D |
27 Jan 2023 16:13 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 25 Jan 2023 | Sale | 10,000 | 315.05 | 3,150,500 | D |
25 Jan 2023 16:08 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 24 Jan 2023 | Sale | 1,489 | 313.36 | 466,593 | D |
25 Jan 2023 16:08 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 24 Jan 2023 | Sale | 2,511 | 312.29 | 784,160 | D |
25 Jan 2023 16:08 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 23 Jan 2023 | Sale | 2,129 | 312.02 | 664,291 | D |
19 Jan 2023 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 18 Jan 2023 | Sale | 442 | 312.17 | 137,979 | D |
19 Jan 2023 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 17 Jan 2023 | Sale | 4,000 | 312.03 | 1,248,120 | D |
17 Nov 2022 16:08 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 15 Nov 2022 | Sale | 34 | 308.61 | 10,493 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 83 | 306.57 | 25,445 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 140 | 305.39 | 42,755 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 280 | 304.58 | 85,282 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 261 | 303.21 | 79,138 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 189 | 301.99 | 57,076 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 210 | 300.96 | 63,202 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 140 | 299.72 | 41,961 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 22 | 317.77 | 6,991 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 10 | 315.68 | 3,157 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 12 | 314.43 | 3,773 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 81 | 313.37 | 25,383 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 100 | 312.4 | 31,240 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 39 | 311.17 | 12,136 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 56 | 310.1 | 17,366 | D |
26 Oct 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 24 Oct 2022 | Sale | 621 | 310 | 192,510 | D |
20 Oct 2022 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 18 Oct 2022 | Sale | 288 | 301.84 | 86,930 | D |
20 Oct 2022 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 18 Oct 2022 | Sale | 1,503 | 300.02 | 450,930 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)